Cargando…
A Comparative Study: Has MRI-guided Fusion Prostate Biopsy Changed the Prostate-specific Antigen Gray-zone Range?
Objective The gray-zone prostate-specific antigen (PSA) range is accepted to be 4-10 ng/ml and is considered to vary according to age. We aimed to investigate whether fusion prostate biopsy (FPB), which has been reported to have relatively higher cancer detection rates, has an effect on gray-zone PS...
Autores principales: | Sönmez, Gökhan, Tombul, Şevket T, Demirtaş, Türev, Öztürk, Figen, Demirtaş, Abdullah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901373/ https://www.ncbi.nlm.nih.gov/pubmed/31857929 http://dx.doi.org/10.7759/cureus.6329 |
Ejemplares similares
-
A Prospective Study and Single-Center Experience: Effectivity of Fusion Prostate Biopsy in Biopsy-Naïve Patients
por: Demirtaş, Türev, et al.
Publicado: (2021) -
A Single-center Experience: Does MRI-guided Target Prostate Biopsy Meet Expectations?
por: Demirtaş, Türev, et al.
Publicado: (2019) -
A Novel Modified Two-Lobe Holmium Prostate Enucleation Technique: Demirtaş–Erciyes Enucleation Prostatectomy
por: Demirtaş, Abdullah, et al.
Publicado: (2022) -
What is the ideal number of biopsy cores per lesion in targeted prostate biopsy?
por: Sonmez, Gokhan, et al.
Publicado: (2020) -
Risk factors associated with pain in fusion prostate biopsy
por: Sonmez, Gokhan, et al.
Publicado: (2020)